Multivalent pneumococcal conjugate vaccine (Tergene Biotech)

N/A

Report date: 2022/12/21 15:42:22

Base Information

Drug NameMultivalent pneumococcal conjugate vaccine (Tergene Biotech)

Drug Alias NamePCV-15

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTergene Biotech

China Registration ClassN/A

Develop Information

Active CompaniesTergene Biotech

Inactive CompaniesN/A

Active IndicationsPneumonia

Inactive IndicationsN/A

Other Information

ATC CodeN/A